Victory Capital Management Increases Holding in Ppl (PPL); Valeant Pharmaceuticals Intl (Put) (VRX) Holder Pomelo Capital Increased Holding

June 15, 2018 - By Nellie Frank

PPL Corporation (NYSE:PPL) Logo

Philip Rosenstrach increased its stake in Valeant Pharmaceuticals Intl (Put) (VRX) by 746.32% based on its latest 2018Q1 regulatory filing with the SEC. Pomelo Capital Llc bought 1.64 million shares as the company’s stock rose 17.86% while stock markets declined. The hedge fund run by Philip Rosenstrach held 1.86M shares of the health care company at the end of 2018Q1, valued at $29.48 million, up from 220,000 at the end of the previous reported quarter. Pomelo Capital Llc who had been investing in Valeant Pharmaceuticals Intl (Put) for a number of months, seems to be bullish on the $9.40B market cap company. The stock increased 0.43% or $0.12 during the last trading session, reaching $26.92. About 3.17 million shares traded. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has risen 73.89% since June 15, 2017 and is uptrending. It has outperformed by 61.32% the S&P500. Some Historical VRX News: 12/03/2018 – S&PGR Rates Valeant Pharmaceuticals Int’l Notes ‘B-‘; 22/05/2018 – Lilly’s Taltz® (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area; 02/05/2018 – KVK Tech, Inc. Announces 1-2-3 Savings Program for Lomaira™ (phentermine hydrochloride USP) 8 mg Tablets, CIV; 26/03/2018 – VALEANT – TENDER OFFERS REMAIN OPEN AND WILL EXPIRE AT 11:59 P.M., NEW YORK CITY TIME, ON APRIL 9, 2018; 02/05/2018 – Valeant Pharmaceuticals: FDA Approves Bausch + Lomb ULTRA Contact Lenses for Extended Wear; 10/05/2018 – PERNIX THERAPEUTICS HOLDINGS INC – AUCTION FOR CONTRAVE’S ASSETS IS CURRENTLY SCHEDULED FOR JUNE 26, 2018; 24/04/2018 – ELI LILLY – 2018 REV GROWTH STILL EXPECTED TO BE DRIVEN BY NEW PRODUCTS INCLUDING TRULICITY, TALTZ, BASAGLAR, JARDIANCE; 12/03/2018 – VALEANT VRX.TO – AGGREGATE SIZE OF OFFERING REFLECTS INCREASE OF $250 MLN FROM PREVIOUSLY ANNOUNCED OFFERING SIZE OF $1.25 BLN TO $1.5 BLN; 10/05/2018 – Valeant Will Borrow More Than $3.82 Bln — MarketWatch; 05/03/2018 VALEANT: PIPER SAYS INSUFFICIENT DIFFERENTIATION, AVAILABILITY OF GENERICS, BRAND COMPETITION, HEAVY PAYER CONTRACTING RENDER LONGER-TERM TARGETS UNREALISTIC

Victory Capital Management Inc increased its stake in Ppl Corp (PPL) by 27.93% based on its latest 2018Q1 regulatory filing with the SEC. Victory Capital Management Inc bought 147,467 shares as the company’s stock declined 7.95% with the market. The institutional investor held 675,444 shares of the central company at the end of 2018Q1, valued at $19.11 million, up from 527,977 at the end of the previous reported quarter. Victory Capital Management Inc who had been investing in Ppl Corp for a number of months, seems to be bullish on the $18.93B market cap company. The stock increased 0.02% or $0.01 during the last trading session, reaching $27.08. About 5.01 million shares traded. PPL Corporation (NYSE:PPL) has declined 31.20% since June 15, 2017 and is downtrending. It has underperformed by 43.77% the S&P500. Some Historical PPL News: 20/03/2018 – PPL Corp Backs 2018 EPS $2.20-EPS $2.40; 20/03/2018 – PPL PLANS TO REAFFIRM 2018 EARNINGS VIEW, CAGR RATE THROUGH ’20; 03/05/2018 – PPL 1Q OPER REV. $2.13B, EST. $2.09B; 06/03/2018 PPL CORP PPL.N : RBC RAISES TO OUTPERFORM FROM SECTOR PERFORM; 20/03/2018 – PPL Corp Backs Compound Annual EPS Growth 5% to 6% Through 2020; 13/03/2018 – Vectren draws three suitors in second round; 15/05/2018 – Kempen Adds PPL, Exits Tapestry, Cuts New York Community: 13F; 16/05/2018 – Scandinavian Investors Buy PPL, Southern; Sell Infosys: 13F; 08/05/2018 – HUHTAMAKI PPL LTD HUHT.NS – MARCH QTR TOTAL REVENUE FROM OPS 5.53 BLN RUPEES VS 5.62 BLN RUPEES YR AGO; 03/05/2018 – PPL Corp 1Q EPS 65c

Victory Capital Management Inc, which manages about $35.27B and $45.84 billion US Long portfolio, decreased its stake in Atricure Inc (NASDAQ:ATRC) by 1.07M shares to 3,265 shares, valued at $67,000 in 2018Q1, according to the filing. It also reduced its holding in Mantech Intl Corp (NASDAQ:MANT) by 13,211 shares in the quarter, leaving it with 1.17M shares, and cut its stake in Netflix Inc (NASDAQ:NFLX).

Among 15 analysts covering PPL Corporation (NYSE:PPL), 7 have Buy rating, 1 Sell and 7 Hold. Therefore 47% are positive. PPL Corporation had 45 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, February 5 by Deutsche Bank. The company was downgraded on Wednesday, August 10 by Guggenheim. As per Sunday, September 24, the company rating was maintained by RBC Capital Markets. On Monday, January 8 the stock rating was maintained by SunTrust with “Buy”. The stock of PPL Corporation (NYSE:PPL) earned “Outperform” rating by Wolfe Research on Wednesday, September 14. Jefferies upgraded the stock to “Buy” rating in Wednesday, July 19 report. On Monday, June 26 the stock rating was upgraded by Goldman Sachs to “Neutral”. The stock of PPL Corporation (NYSE:PPL) has “Outperform” rating given on Tuesday, March 6 by RBC Capital Markets. The firm earned “Neutral” rating on Tuesday, November 22 by Bank of America. KeyBanc Capital Markets maintained the stock with “Hold” rating in Wednesday, October 18 report.

Investors sentiment decreased to 0.74 in 2018 Q1. Its down 0.41, from 1.15 in 2017Q4. It dived, as 73 investors sold PPL shares while 255 reduced holdings. 64 funds opened positions while 179 raised stakes. 482.80 million shares or 0.69% more from 479.50 million shares in 2017Q4 were reported. Flippin Bruce & Porter accumulated 156,897 shares. M&T Bancshares reported 0.03% in PPL Corporation (NYSE:PPL). Town & Country Bank & Tru Dba First Bankers Tru has invested 1.28% in PPL Corporation (NYSE:PPL). Schwab Charles Inv Mgmt stated it has 0.06% of its portfolio in PPL Corporation (NYSE:PPL). San Francisco Sentry Invest (Ca) has invested 0% in PPL Corporation (NYSE:PPL). Captrust Financial Advisors accumulated 819 shares. Td Asset Inc stated it has 1.98 million shares or 0.09% of all its holdings. Financial Professionals Incorporated accumulated 200 shares. Mitsubishi Ufj Trust And reported 0.08% stake. Willis Investment Counsel owns 348,600 shares. 24,945 are owned by Kessler Limited. Silvercrest Asset Grp Incorporated Limited Liability Com owns 10,519 shares. Tarbox Family Office Inc reported 0% in PPL Corporation (NYSE:PPL). Caxton Associate LP reported 0.07% in PPL Corporation (NYSE:PPL). Cubist Systematic Strategies Limited Liability owns 23,531 shares or 0.04% of their US portfolio.

More recent PPL Corporation (NYSE:PPL) news were published by: Seekingalpha.com which released: “PPL Update: Has The Story Changed?” on May 26, 2018. Also Globenewswire.com published the news titled: “Factors of Influence in 2018, Key Indicators and Opportunity within PPL, The Travelers Companies, Xilinx, United …” on June 12, 2018. Seekingalpha.com‘s news article titled: “PPL – Equity Raise, More To Come?” with publication date: June 03, 2018 was also an interesting one.

Since March 8, 2018, it had 4 insider purchases, and 0 sales for $1.20 million activity. On Thursday, March 8 DE SCHUTTER RICHARD U bought $153,400 worth of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) or 10,000 shares. 30,000 shares valued at $481,500 were bought by PAPA JOSEPH C on Tuesday, March 13.

Among 28 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 9 have Buy rating, 5 Sell and 14 Hold. Therefore 32% are positive. Valeant Pharmaceuticals Intl had 171 analyst reports since July 21, 2015 according to SRatingsIntel. Rodman & Renshaw maintained it with “Buy” rating and $118 target in Wednesday, March 16 report. The stock of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has “Buy” rating given on Tuesday, August 9 by Rodman & Renshaw. RBC Capital Markets maintained Valeant Pharmaceuticals International, Inc. (NYSE:VRX) on Tuesday, November 3 with “Outperform” rating. The company was maintained on Tuesday, November 7 by Cantor Fitzgerald. The firm has “Buy” rating by Cantor Fitzgerald given on Friday, January 19. The company was downgraded on Wednesday, November 23 by Mizuho. The rating was downgraded by Mizuho on Monday, March 21 to “Underperform”. The firm has “Buy” rating by Rodman & Renshaw given on Monday, April 11. The firm has “Sell” rating given on Wednesday, July 12 by Piper Jaffray. As per Thursday, November 9, the company rating was maintained by BTIG Research.

More notable recent Valeant Pharmaceuticals International, Inc. (NYSE:VRX) news were published by: Schaeffersresearch.com which released: “Options Bulls Blitz Booming Valeant Pharmaceuticals Stock” on June 05, 2018, also Seekingalpha.com with their article: “Valeant Pharmaceuticals: Worth At Least $30” published on May 21, 2018, Finance.Yahoo.com published: “Can Sprout Pharma’s Latest Revival Really Boost VRX Stock?” on June 15, 2018. More interesting news about Valeant Pharmaceuticals International, Inc. (NYSE:VRX) were released by: Gurufocus.com and their article: “Bill Ackman’s Picks Looking Up” published on June 14, 2018 as well as Fool.ca‘s news article titled: “Is Aurora Cannabis Inc. (TSX:ACB) Pulling a Valeant Pharmaceuticals Intl Inc. (TSX:VRX)?” with publication date: June 14, 2018.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: